Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of
1934
Date of Report
(Date of earliest event reported) March
5, 2019
|
SANUWAVE Health, Inc.
|
|
(Exact
name of registrant as specified in its charter)
|
|
Nevada
|
|
000-52985
|
|
20-1176000
|
|
(State or other
jurisdiction of incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.)
|
|
3360 Martin Farm Road, Suite 100, Suwanee, Georgia
|
|
30024
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (770)
419-7525
|
N/A
|
|
(Former
name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registration is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933
or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company. ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item
7.01
Regulation FD Disclosure
On
March 5, 2019, SANUWAVE Health, Inc., a Nevada corporation (the
“Company”), posted to its corporate website a
presentation to be given by the management of the Company to
investors to provide an overview of the Company. A copy of
management’s presentation slides are attached hereto as
Exhibit
99.1.
The
information in this Item 7.01 of this Current Report on Form 8-K
and the exhibit attached hereto shall not be deemed to be
“filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, and shall not be deemed
incorporated by reference in any filing under the Securities Act of
1933, as amended, except as shall be expressly set forth by
specific reference in such filing.
Item
9.01
Financial Statements and Exhibits.
(d)
Exhibits.
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
|
|
Management
Presentation for investor meetings dated March
2019.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
SANUWAVE
HEALTH, INC.
|
|
|
|
|
|
|
|
Dated: March 5,
2019
|
By:
|
/s/ Lisa E.
Sundstrom
|
|
|
|
|
Name: Lisa E.
Sundstrom
|
|
|
|
|
Title:
Chief
Financial Officer
|
|